Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Non Operating Income: 2012-2024

Historic Non Operating Income for Neurogene (NGNE) over the last 10 years, with Dec 2024 value amounting to $7.5 million.

  • Neurogene's Non Operating Income rose 44.93% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.2 million, marking a year-over-year increase of 106.72%. This contributed to the annual value of $7.5 million for FY2024, which is 61.27% down from last year.
  • As of FY2024, Neurogene's Non Operating Income stood at $7.5 million, which was down 61.27% from $19.3 million recorded in FY2023.
  • In the past 5 years, Neurogene's Non Operating Income ranged from a high of $19.3 million in FY2023 and a low of $7.5 million during FY2024.
  • For the 2-year period, Neurogene's Non Operating Income averaged around $13.4 million, with its median value being $13.4 million (2023).
  • Data for Neurogene's Non Operating Income shows a maximum YoY crashed of 61.27% (in 2024) over the last 5 years.
  • Over the past 2 years, Neurogene's Non Operating Income (Yearly) stood at $19.3 million in 2023, then tumbled by 61.27% to $7.5 million in 2024.